1. | laraelinds | |
2. | maldd | |
3. | mb45330sze |
1. | laraelinds | |
2. | maldd | |
3. | mb45330sze |
1. | mb45330sze 05/17/2018 Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results |
2. | maldd 02/20/2018 Announces successful End-of-Phase II meeting with FDA for DCCR in Prader-Willi syndrome |
3. | laraelinds 02/13/2018 Maxim Group sets PT at $4 |
4. | laraelinds 07/30/2018 Maxim Group sets PT at $4 |
5. | laraelinds 01/31/2018 NEWS OUT!!! $SLNO - Files for 14,165,541 share common stock offering by stockholders including 6,024,425 warrant shares that may… |